Question 1

What are the most cited papers from MedVadis Research?

Accepted Answer

The most cited paper from MedVadis Research is "Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study" (MARCELO EDUARDO BIGAL, Lars IH Edvinsson, Alan M. Rapoport et al., 2015), with 264 citations. Next come "Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine" (69) and "Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine" (47).

Question 2

Which research topics does MedVadis Research publish most on?

Accepted Answer

By volume in 2022-now: Migraine and Headache Studies, Olfactory and Sensory Function Studies, Dental Anxiety and Anesthesia Techniques and Allergic Rhinitis and Sensitization.

Question 3

Which fields of science does MedVadis Research work in?

Accepted Answer

In all years, 83% of research at MedVadis Research is in Health Sciences, 17% in Life Sciences. Its largest fields are Medicine (78%), Neuroscience (13%), Dentistry (5%). It does 2.0× the world's share of Health Sciences.

Question 4

Is MedVadis Research's research output growing?

Accepted Answer

Output in 2022-2025 was 26% lower than in 2018-2021.